Nucleome Therapeutics

Curated by Signal

Developer of nucleome therapeutics for multiple diseases

Overview

Nucleome is a developer of nucleome therapeutics for multiple diseases. It has developed new drug targets for autoimmune diseases by using a non-coding genome for human health. It combines bioinformatics, genomics, and the 3D structure of chromosomes that enables it to develop drugs for various diseases. It helps in gene regulation, genomics, machine learning, data analysis.

Key facts

Founded: 2019
Headquarters: Headington, United Kingdom
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Drive Medical
A manufacturer and distributor of durable medical products
Life Sciences TechnologyElland, United Kingdom
CanCertain
Developer of personalized tests to detect cancer for precision medicines
Life Sciences TechnologyRuncorn, United Kingdom
Casmed
Products for the treatment of infertility
Life Sciences TechnologyEpsom, United Kingdom

About Nucleome Therapeutics

What does Nucleome Therapeutics do?

Nucleome is a developer of nucleome therapeutics for multiple diseases.

Where is Nucleome Therapeutics headquartered?

Nucleome Therapeutics is headquartered in Headington, United Kingdom.

When was Nucleome Therapeutics founded?

Nucleome Therapeutics was founded in 2019.

Which sector is Nucleome Therapeutics in?

Nucleome Therapeutics operates in Life Sciences Technology.

Who are Nucleome Therapeutics's competitors?

Companies similar to Nucleome Therapeutics include Drive Medical, CanCertain, and Casmed.